probuphine Drug Patent Profile
✉ Email this page to a colleague
When do Probuphine patents expire, and what generic alternatives are available?
Probuphine is a drug marketed by Reacx Pharms and is included in one NDA. There is one patent protecting this drug.
This drug has sixteen patent family members in thirteen countries.
The generic ingredient in PROBUPHINE is buprenorphine hydrochloride. There are twenty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Probuphine
A generic version of probuphine was approved as buprenorphine hydrochloride by HOSPIRA on June 3rd, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for probuphine?
- What are the global sales for probuphine?
- What is Average Wholesale Price for probuphine?
Summary for probuphine
International Patents: | 16 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 19 |
Clinical Trials: | 8 |
Patent Applications: | 5,082 |
Drug Prices: | Drug price information for probuphine |
What excipients (inactive ingredients) are in probuphine? | probuphine excipients list |
DailyMed Link: | probuphine at DailyMed |
![probuphine drug patent expirations Drug patent expirations by year for probuphine](/p/graph/s/t/probuphine-patent-expirations.png)
![Drug Prices for probuphine](/p/graph/drug-price/probuphine.png)
Recent Clinical Trials for probuphine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medical College of Wisconsin | Phase 2 |
Braeburn Pharmaceuticals | Phase 3 |
National Institute on Drug Abuse (NIDA) | Phase 3 |
US Patents and Regulatory Information for probuphine
probuphine is protected by one US patents.
Patents protecting probuphine
Implantable polymeric device for sustained release of buprenorphine
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: FOR OPIOID DEPENDENCE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reacx Pharms | PROBUPHINE | buprenorphine hydrochloride | IMPLANT;IMPLANTATION | 204442-001 | May 26, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for probuphine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Reacx Pharms | PROBUPHINE | buprenorphine hydrochloride | IMPLANT;IMPLANTATION | 204442-001 | May 26, 2016 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for probuphine
See the table below for patents covering probuphine around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2665999 | ⤷ Sign Up | |
European Patent Office | 2561860 | Dispositif polymère implantable pour libération prolongée de buprénorphine (Implantable polymeric device for sustained release of buprenorphine) | ⤷ Sign Up |
Japan | 2005528422 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 03101358 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |